Encompass Health stock reports a Q2 earnings beat
Published on 09/25/2026 at 10:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Encompass Health stock was trading at USD 122.01 on the NYSE on September 24, 2026, while the company delivered adjusted EPS of USD 1.55 in Q2/2026. The result exceeded the USD 1.48 consensus estimate and gives the stock a clear earnings anchor as the third quarter develops.
Q2 revenue reaches USD 1.60 billion
According to MarketBeat, Encompass Health reported Q2 revenue of USD 1.60 billion, up 9.6 percent from the same quarter a year earlier. Adjusted EPS of USD 1.55 was USD 0.07 above the consensus estimate, creating a direct comparison between operating performance and expectations.
The financial profile is also visible in the reported quarterly figures: operating profit reached USD 288.4 million and consolidated net income was USD 208.0 million in Q2/2026. The operating margin was 18.0 percent for the period, making revenue growth and cost control the central earnings indicators.
Guidance sets the next benchmark
Full-year 2026 adjusted EPS guidance stands at USD 6.02-6.25, while net operating revenue guidance is USD 6.41-6.49 billion, according to Zacks. The revenue range is higher than the earlier projection of USD 6.375-6.475 billion, so the guidance revision gives investors a measurable benchmark for the rest of 2026.
Capacity expansion provides a second operating reference. A StockTitan release dated September 15, 2026, said the company opened a 50-bed inpatient rehabilitation hospital in Pennsylvania. New beds expand treatment capacity, linking the guidance increase to a concrete growth investment.
Stock remains below its yearly high
Encompass Health stock stood at USD 122.01 on the NYSE on September 24, 2026, down USD 0.20 or 0.16 percent from the prior close. The price was 4.7 percent below the 52-week high of USD 127.99 and the market capitalization was USD 12,103,279,751 on the same date.
Encompass Health at a glance
- Company: Encompass Health Corporation
- Ticker: EHC
- Trading venue: NYSE
- Price as of September 24, 2026: USD 122.01
- Market capitalization: USD 12,103,279,751 as of September 24, 2026
- 52-week range: USD 92.77-127.99 as of September 24, 2026
- Sector / Industry: Healthcare / Medical Care Facilities
